ALB and myeloid sarcoma: Accordingly, these researchers demonstrated that immunoglobin synthesis, as a biomarker of MS, can be established with simple CSF/serum κ-FLC quotients and the given albumin CSF/serum concentration quotient (quotient diagram) [28,111].